Exchange: NYSE·Updated 05:33 PM EDT
PFE logo

PFEPfizer Inc

$24.23
$0.20
(0.83%)
Today
Closed $24.25
$0.02
(0.08%)
After Hours
EarningsAug 4
Mkt Cap$137.07B
Vol28.72M
News
all
press releases
NYC Tower Owner Prepares To Rebuild 15 Floors After I-Beam Failure
NYC Tower Owner Prepares To Rebuild 15 Floors After I-Beam Failure Fears of a possible collapse at a condo tower?under construction near Grand Central Terminal had abated by the end of the week, but the incident only signals the massive engineering challenges tied to Manhattan's...
Zero Hedge
News Placeholder
More News
News Placeholder
BridgeBio Stock Taps Rare Disease Trends and New Diagnosis Growth
BBIO builds on Attruby's launch as rising rare disease diagnoses and late-stage pipeline candidates set up multiple potential U.S. launches.
Zacks
News Placeholder
Is BBIO Stock a Buy Now or Too Expensive for the Risk Ahead
BridgeBio Pharma's Attruby sales are surging, but can growth keep justifying its premium valuation amid execution risks and rising costs?
Zacks
News Placeholder
BridgeBio Stock Outlook Hinges on Attruby & New Drug Catalysts
BBIO's outlook hinges on Attruby growth, upcoming drug launch catalysts and execution as it seeks to diversify beyond its lone marketed therapy.
Zacks
News Placeholder
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Zacks
News Placeholder
3 Cancer Stocks to Watch as Oncology Innovation Accelerates
Oncology innovation is reshaping cancer care as AI, immunotherapy and targeted therapies fuel pipeline growth and spotlight promising cancer-focused stocks.
Zacks
News Placeholder
"I-Beams Bending Like Cigarettes": Former Pfizer HQ Tower In Midtown At Risk Of Collapse
"I-Beams Bending Like Cigarettes": Former Pfizer HQ Tower In Midtown At Risk Of Collapse Dramatic video from inside the former Pfizer headquarters tower in Midtown Manhattan shows large I-beams buckling, and officials are warning of a possible collapse. The 33-story high-rise at 235...
Zero Hedge
News Placeholder
Opinion: Pfizer's Dividend Is Riskier Than You Might Think
Key PointsPfizer's estimated 2026 earnings easily cover its generous dividend...
Nasdaq News: Markets
News Placeholder
Pfizer or AstraZeneca: Which Stock Offers Better Long-Term Potential?
AZN targets continued 2026 growth with expanding blockbuster medicines, a strong pipeline and 2030 revenue goals as it outpaces Pfizer on key metrics.
Zacks
News Placeholder
Pfizer (PFE) Stock Sinks As Market Gains: Here's Why
Pfizer (PFE) concluded the recent trading session at $23.72, signifying a -2.47% move from its prior day's close.
Zacks
<
1
2
...
>

Advertisement|Remove ads.